Skip to main content
SpringerLink
Log in
Book cover

Antibiotics as Anti-Inflammatory and Immunomodulatory Agents pp 5–24Cite as

Effects of antibiotics on Pseudomonas aeruginosa virulence factors and quorum-sensing system

  • Chapter

Part of the book series: Progress in Inflammation Research ((PIR))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Richards MJ, Edwards JR, Culver DH, Gaynes RP (1999) Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27(5): 887–92

    Article  PubMed  Google Scholar 

  2. Hoiby N (1994) Diffuse panbronchiolitis and cystic fibrosis: East meets West. Thorax 49(6): 531–2

    PubMed  Google Scholar 

  3. Wilson R, Dowling RB (1998) Lung infections. 3. Pseudomonas aeruginosa and other related species. Thorax 53(3): 213–19

    PubMed  Google Scholar 

  4. Passador L, Cook JM, Gambello MJ, Rust L, Iglewski BH (1993) Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication. Science 260(5111): 1127–30

    PubMed  Google Scholar 

  5. Kaplan HB, Greenberg EP (1985) Diffusion of autoinducer is involved in regulation of the Vibrio fischeri luminescence system. J Bacteriol 163(3): 1210–14

    PubMed  Google Scholar 

  6. Pearson JP, Gray KM, Passador L, Tucker KD, Eberhard A, Iglewski BH, Greenberg EP (1994) Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc Natl Acad Sci USA 91(1): 197–201

    PubMed  Google Scholar 

  7. Pearson JP, Passador L, Iglewski BH, Greenberg EP (1995) A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. Proc Natl Acad Sci USA 92(5):1490–4

    PubMed  Google Scholar 

  8. Kudoh S, Kimura H (1984) Clinical effect of low-dose long-term administration of macrolides on diffuse panbronchiolits. Jpn J Thorac Dis 22: 254

    Google Scholar 

  9. Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus LH, Kimura H, Sugiyama Y (1987) Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 25(6): 632–42

    Google Scholar 

  10. Peters DH, Friedel HA, McTavish D (1992) Azithromycin: A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 44(5): 750–99

    PubMed  Google Scholar 

  11. Wilson JT, van Boxtel CJ (1978) Pharmacokinetics of erythromycin in man. Antibiot Chemother 25: 181–203

    PubMed  Google Scholar 

  12. Kirst HA, Sides GD (1989) New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrob Agents Chemother 33(9): 1419–22

    PubMed  Google Scholar 

  13. Butts JD (1994) Intracellular concentrations of antibacterial agents and related clinical implications. Clin Pharmacokinet 27(1): 63–84

    PubMed  Google Scholar 

  14. Tulkens PM (1991) Intracellular distribution and activity of antibiotics. Eur J Clin Microbiol Infect Dis 10(2): 100–106

    Google Scholar 

  15. Gladue RP, Bright GM, Isaacson RE, Newborg MF (1989) In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 33(3): 277–82

    PubMed  Google Scholar 

  16. Tateda K, Ishii Y, Matsumoto T, Furuya N, Nagashima M, Matsunaga T, Ohno A, Miyazaki S, Yamaguchi K (1996) Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. Antimicrob Agents Chemother 40(10): 2271–5

    PubMed  Google Scholar 

  17. Pollack M (1984) The virulence of Pseudomonas aeruginosa. Rev Infect Dis 6(Suppl 3):S617–626

    PubMed  Google Scholar 

  18. Molinari G, Paglia P, Schito GC (1992) Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin. Eur J Clin Microbiol Infect Dis 11(5): 469–71

    Article  PubMed  Google Scholar 

  19. Molinari G, Guzman CA, Pesce A, Schito GC (1993) Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J Antimicrob Chemother 31(5): 681–8

    PubMed  Google Scholar 

  20. Sato K, Suga M, Nishimura J, Kushima Y, Muranaka H, Ando M (1997) Pyocyanine synthesis by Pseudomonas aeruginosa in chronic airway infection and the effect of erythromycin on its biological activity. Jpn J Antibiot 50(Suppl): 89–91

    PubMed  Google Scholar 

  21. Kita E, Sawaki M, Oku D, Hamuro A, Mikasa K, Konishi M, Emoto M, Takeuchi S, Narita N, Kashiba S (1991) Suppression of virulence factors of Pseudomonas aeruginosa by erythromycin. J Antimicrob Chemother 27(3): 273–84

    PubMed  Google Scholar 

  22. Sakata K, Yajima H, Tanaka K, Sakamoto Y, Yamamoto K, Yoshida A, Dohi Y (1993) Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro. Am Rev Respir Dis 148(4 Pt 1): 1061–5

    PubMed  Google Scholar 

  23. Hirakata Y, Kaku M, Mizukane R, Ishida K, Furuya N, Matsumoto T, Tateda K, Yamaguchi K (1992) Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa. Antimicrob Agents Chemother 36(9): 1922–7

    PubMed  Google Scholar 

  24. Mizukane R, Hirakata Y, Kaku M, Ishii Y, Furuya N, Ishida K, Koga H, Kohno S, Yamaguchi K (1994) Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa. Antimicrob Agents Chemother 38(3): 528–33

    PubMed  Google Scholar 

  25. Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60(3): 539–74

    PubMed  Google Scholar 

  26. Yasuda H, Ajiki Y, Koga T, Kawada H, Yokota T (1993) Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother 37(9): 1749–55

    PubMed  Google Scholar 

  27. Ichimiya T, Yamasaki T, Nasu M (1994) In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation. J Antimicrob Chemother 34(3): 331–41

    PubMed  Google Scholar 

  28. Ichimiya T, Takeoka K, Hiramatsu K, Hirai K, Yamasaki T, Nasu M (1996) The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. Chemotherapy 42(3): 186–91

    PubMed  Google Scholar 

  29. Kobayashi H (1995) Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides. Am J Med 99(6A): 26S–30S

    Article  PubMed  Google Scholar 

  30. Ripoll L, Reinert P, Pepin LF, Lagrange PH (1996) Interaction of macrolides with alpha dornase during DNA hydrolysis. J Antimicrob Chemother37(5): 987–91

    PubMed  Google Scholar 

  31. Menninger JR, Coleman RA, Tsai LN (1994) Erythromycin, lincosamides, peptidyl-tRNA dissociation, and ribosome editing. Mol Gen Genet 243(2): 225–33

    PubMed  Google Scholar 

  32. Tateda K, Ishii Y, Hirakata Y, Matsumoto T, Ohno A, Yamaguchi K (1994) Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity. J Antimicrob Chemother 34(6): 931–42

    PubMed  Google Scholar 

  33. Tateda K, Hirakata Y, Furuya N, Ohno A, Yamaguchi K (1993) Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa. Antimicrob Agents Chemother 37(4): 675–80

    PubMed  Google Scholar 

  34. Shibl AM (1985) Effect of antibiotics on adherence of microorganisms to epithelial cell surfaces. Rev Infect Dis 7(1): 51–65

    PubMed  Google Scholar 

  35. Yamasaki T, Ichimiya T, Hirai K, Hiramatsu K, Nasu M (1997) Effect of antimicrobial agents on the piliation of Pseudomonas aeruginosa and adherence to mouse tracheal epithelium. J Chemother 9(1): 32–7

    PubMed  Google Scholar 

  36. Kawamura-Sato K, Iinuma Y, Hasegawa T, Horii T, Yamashino T, Ohta M (2000) Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis. Antimicrob Agents Chemother 44(10): 2869–72

    Article  PubMed  Google Scholar 

  37. Saiman L, Chen Y, Gabriel PS, Knirsch C (2002) Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob Agents Chemother 46(4): 1105–7

    Article  PubMed  Google Scholar 

  38. Bui KQ, Banevicius MA, Nightingale CA, Quintiliani R, Nicolau DP (2000) In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa. J Antimicrob Chemother 45(1): 57–62

    Article  PubMed  Google Scholar 

  39. Yanagihara K, Tomono K, Sawai T, Kuroki M, Kaneko Y, Ohno H, Higashiyama Y, Miyazaki Y, Hirakata Y, Maesaki S et al (2000) Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. J Antimicrob Chemother 46(1): 69–72

    Article  PubMed  Google Scholar 

  40. Tateda K, Ishii Y, Matsumoto T, Kobayashi T, Miyazaki S, Yamaguchi K (2000) Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response. J Infect Chemother 6(1): 1–7

    Article  PubMed  Google Scholar 

  41. Lam J, Chan R, Lam K, Costerton JW (1980) Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 28(2):546–56

    PubMed  Google Scholar 

  42. Gilligan PH (1991) Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 4(1): 35–51

    PubMed  Google Scholar 

  43. Gambello MJ, Iglewski BH (1991) Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol 173(9): 3000–9

    PubMed  Google Scholar 

  44. Ochsner UA, Koch AK, Fiechter A, Reiser J (1994) Isolation and characterization of a regulatory gene affecting rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa. J Bacteriol 176(7): 2044–54

    PubMed  Google Scholar 

  45. Rumbaugh KP, Griswold JA, Iglewski BH, Hamood AN (1999) Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect Immun 67(11): 5854–62

    PubMed  Google Scholar 

  46. Pearson JP, Feldman M, Iglewski BH, Prince A (2000) Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection. Infect Immun 68(7): 4331–4

    Article  PubMed  Google Scholar 

  47. Smith RS, Harris SG, Phipps R, Iglewski BH (2002) The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)homoserine lactone contributes to virulence and induces inflammation in vivo. J Bacteriol 184(4): 1132–9

    Article  PubMed  Google Scholar 

  48. Wu H, Song Z, Givskov M, Doring G, Worlitzsch D, Mathee K, Rygaard J, Hoiby N (2001) Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection. Microbiology 147 (Pt 5): 1105–13

    PubMed  Google Scholar 

  49. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP (2000) Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407(6805): 762–4

    Article  PubMed  Google Scholar 

  50. Parsek MR, Greenberg EP (1999) Quorum sensing signals in development of Pseudomonas aeruginosa biofilms. Methods Enzymol 310: 43–55

    PubMed  Google Scholar 

  51. Parsek MR, Greenberg EP (2000) Acyl-homoserine lactone quorum sensing in gram-negative bacteria: a signaling mechanism involved in associations with higher organisms. Proc Natl Acad Sci USA 97(16): 8789–93

    Article  PubMed  Google Scholar 

  52. De Kievit TR, Iglewski BH (1999) Quorum sensing, gene expression, and Pseudomonas biofilms. Methods Enzymol 310: 117–28

    PubMed  Google Scholar 

  53. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG (2002) Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 184(4): 1140–54

    Article  PubMed  Google Scholar 

  54. Storey DG, Ujack EE, Rabin HR, Mitchell I (1998) Pseudomonas aeruginosa lasR transcription correlates with the transcription of lasA, lasB, and toxA in chronic lung infections associated with cystic fibrosis. Infect Immun 66(6): 2521–8

    PubMed  Google Scholar 

  55. Erickson DL, Endersby R, Kirkham A, Stuber K, Vollman DD, Rabin HR, Mitchell I, Storey DG (2002) Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis. Infect Immun 70(4):1783–90

    Article  PubMed  Google Scholar 

  56. Charlton TS, de Nys R, Netting A, Kumar N, Hentzer M, Givskov M, Kjelleberg S (2000) A novel and sensitive method for the quantification of N-3-oxoacyl homoserine lactones using gas chromatography-mass spectrometry: application to a model bacterial biofilm. Environ Microbiol 2(5): 530–41

    Article  PubMed  Google Scholar 

  57. DiMango E, Zar HJ, Bryan R, Prince A (1995) Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 96(5): 2204–10

    PubMed  Google Scholar 

  58. Smith RS, Fedyk ER, Springer TA, Mukaida N, Iglewski BH, Phipps RP (2001) IL-8 production in human lung fibroblasts and epithelial cells activated by the Pseudomonas autoinducer N-3-oxododecanoyl homoserine lactone is transcriptionally regulated by NF-kappa B and activator protein-2. J Immunol 167(1): 366–74

    PubMed  Google Scholar 

  59. Tateda K, Ishii Y, Horikawa M, Matsumoto T, Miyairi S, Pechere JC, Standiford TJ, Ishiguro M, Yamaguchi K (2003) The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils. Infect Immun 71(10): 5785–93

    Article  PubMed  Google Scholar 

  60. de Kievit TR, Iglewski BH (2000) Bacterial quorum sensing in pathogenic relationships. Infect Immun 68(9): 4839–49

    Article  PubMed  Google Scholar 

  61. Miller MB, Bassler BL (2001) Quorum sensing in bacteria. Annu Rev Microbiol 55:165–99

    Article  PubMed  Google Scholar 

  62. Whitehead NA, Barnard AM, Slater H, Simpson NJ, Salmond GP (2001) Quorum-sensing in Gram-negative bacteria. FEMS Microbiol Rev 25(4): 365–404

    Article  PubMed  Google Scholar 

  63. Schauder S, Bassler BL (2001) The languages of bacteria. Genes Dev 15(12): 1468–80

    Article  PubMed  Google Scholar 

  64. Reverchon S, Chantegrel B, Deshayes C, Doutheau A, Cotte-Pattat N (2002) New synthetic analogues of N-acyl homoserine lactones as agonists or antagonists of transcriptional regulators involved in bacterial quorum sensing. Bioorg Med Chem Lett 12(8): 1153–7

    Article  PubMed  Google Scholar 

  65. Smith KM, Bu Y, Suga H (2003) Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs. Chem Biol 10(1): 81–9

    Article  PubMed  Google Scholar 

  66. Hentzer M, Wu H, Andersen JB, Riedel K, Rasmussen TB, Bagge N, Kumar N, Schembri MA, Song Z, Kristoffersen P et al (2003) Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. Embo J 22(15): 3803–15

    Article  PubMed  Google Scholar 

  67. Tateda K, Comte R, Pechere JC, Kohler T, Yamaguchi K, Van Delden C (2001) Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45(6): 1930–3

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Infectious Disease, Toho University School of Medicine, 5-21-16 Ohmorinishi, Ohtaku, Tokyo, 143-8540, Japan

    Kazuhiro Tateda & Keizo Yamaguchi

  2. Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA

    Theodore J. Standiford

Authors
  1. Kazuhiro Tateda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theodore J. Standiford
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keizo Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pediatrics School of Medicine, Wake Forest University, Medical Center Boulevard, Winston-Salem, NC, 27157-1081, USA

    Bruce K. Rubin

  2. First Department of Medicine, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku, Tokyo, 162-8666, Japan

    Jun Tamaoki

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Tateda, K., Standiford, T.J., Yamaguchi, K. (2005). Effects of antibiotics on Pseudomonas aeruginosa virulence factors and quorum-sensing system. In: Rubin, B.K., Tamaoki, J. (eds) Antibiotics as Anti-Inflammatory and Immunomodulatory Agents. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7310-5_1

Download citation

  • DOI: https://doi.org/10.1007/3-7643-7310-5_1

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-7643-5925-6

  • Online ISBN: 978-3-7643-7310-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation